Drug Discovery Informatics Market: Global Industry Research Report 2020-2027 | Envisage Research
Envisage report cover

Drug Discovery Informatics Market - By End user (Pharmaceutical companies, Biotechnology companies, Contract Research Organization and Other End users), By solution (Software and Services), By Application (Drug development and Drug Discovery), By Function (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management and Others), By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) and Industry Analysis, Opportunity and Forecast 2021 To 2027

Published Date: May 2021

No. of Pages: 183

Status: Published

Report Code: EMR100637

The global drug discovery informatics market is projected to reach USD 3.7 billion in 2027 from USD 2.2 billion in 2020, at a CAGR of 9.3 % during the forecast period. Introduction of in silico tools, which enable computation with varied workflows that are in sync with rate of modern medicinal chemistry, is one of the key trends stimulating market growth. Drug discovery is a functional process in pharmaceutical and biotechnology companies. It involves different steps and procedures that depend on in-silico tools for reducing the complexity of a process.

Identification of lead molecules requires synthesis and analysis of many derivatives that can be prepared with the help of in silico modelling tools. Success of a drug discovery experiment depends extensively on effectiveness of tools employed to assess varied aspects of drugs. In silico tools used herein include modelling tools for determination of 3D structures of ligand and protein-ADMET assessment-affinity estimation in docking and drug-ligand interaction for pharmacological profiling.

Major market participants are involved in adoption of in silico modelling tools, which is expected to work in favour of the market. In silico tools are promising tools that provide valuable structural screening and information validation at a fraction of the cost of traditional methods, shortening the discovery process to a great extent.

Migration from expensive and large mainframe computers as well as shared clusters to personal supercomputers, powerful desktops, small workgroup clusters, or laptops is extending the full potential of next-generation discovery information processing provided to a broader range of scientists. The onus is shifting to software developers, who need to create scientific software products that are easy to use, in order to most effectively exploit the power of inexpensive computing.

Advancements with respect to fundamental algorithms employed by computational information processing for predictive chemistry, which lead to improvement in scientific innovation and laboratory informatics, are likely to augment the market in the coming years. This group of “front-line” scientific applications, part of a category of software generally referred to as “laboratory informatics,” is a critical component in the redefinition of discovery information processing and is increasingly being used by laboratory chemists and biologists.

The major companies in the drug discovery informatics market include Charles River Laboratories International, Inc., Thermo Fisher Scientific, PerkinElmer Inc., Biogen Inc., BoehringerIngelheim GmbH, Insilico Medicine, Inc., International Business Machines Corporation, Schrodinger, LLC, Albany Molecular Research Inc. (AMRI), and Certara, L.P. These players are adopting the growth strategies that increase their product offerings, strengthen their geographical reach, increase customer base and garner market share. For instance, In September 2016, Charles River Laboratories International, Inc. acquired Agilux Laboratories, a contract based research organization which provides bio analytical services.

Analyst Commentary

Market growth is largely driven by factors such as the rising R&D expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery. However, the scarcity of skilled professionals and the high setup cost of informatics software are expected to limit market growth to a certain extent.

The pharmaceutical companies segment accounted for the largest share of the drug discovery informatics market in 2019; pharmaceutical companies are using this informatics software extensively for pre-clinical research & development, target identification, compound screening and lead identification, and streamlining their drug discovery process which is the major factor for driving the growth of this segment.

The sequencing and target data analysis segment accounted for the largest share of the drug discovery informatics market for the function segment of the market in 2019. The large share of this segment can be attributed to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains.

Segmentation

The Global Drug Discovery Informatics Market is classified on the basis of application, solution, function, end-user, and region. Based on the application, the market is divided into drug development, and drug discovery.. Based on function the market can be classified into sequencing and target data analysis, docking, lead generation informatics, identification & validation informatics, molecular modelling, and others. In terms of end-user the market can be divided into contract research organizations, pharmaceutical & biotechnology companies, and others. Based on solution the market is segmented into software and services.

Regional Analysis

The drug discovery informatics market is divided into four major regions-north America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the global drug discovery informatics market, closely followed by Europe. The large share of North America in the global market can be attributed to the presence of well-established CROs, rising R&D expenditure by pharmaceutical and biopharmaceutical companies

The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the rapid growth in the pharmaceutical and biopharmaceutical industry, rising number of CROs, and the presence of less-stringent regulations for drug discovery processes
North America dominated the market owing to higher incidence rates of different infectious diseases and oncology diseases. Simultaneous developments of next generation sequencing and chemical laboratories in the region are among the primary growth stimulants of the market for drug discovery informatics.

Asia Pacific provides a substantial cost saving advantage, with savings ranging from 50% to 80% of the cost as compared to developed nations, thus leading to an augmentation in the volume of clinical trials being conducted in this region. This is, thereby, providing a significant push to the regional market. The region is expected to experience the fastest growth during the regional market.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Engine Powered of Suppliers
3.7.2. Bargaining Engine Powered of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Drug Discovery Informatics Market
Chapter 5. Global Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
5.1. Global Drug Discovery Informatics Market Share, By Solutions, 2015 - 2027 (USD Billion)
5.1.1. Software
5.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Services
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Drug Discovery Informatics Market Overview, By Functions, 2015 - 2027 (USD Billion)
6.1. Global Drug Discovery Informatics Market Share, By Functions, 2015 - 2027 (USD Billion)
6.1.1. SEQUENCING
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. TARGET DATA ANALYSIS
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Docking
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Lead generation informatics
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Drug Discovery Informatics Market Overview, By End-users, 2015 - 2027 (USD Billion)
7.1. Global Drug Discovery Informatics Market Share, By End-users, 2015 - 2027 (USD Billion)
7.1.1. Contract research organizations
7.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.2. Pharmaceutical & biotechnology companies
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.3. Others
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 8. Global Drug Discovery Informatics Market Overview, By Application, 2015 - 2027 (USD Billion)
8.1. Global Drug Discovery Informatics Market Share, By Application, 2015 - 2027 (USD Billion)
8.1.1. Drug development
8.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
8.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
8.1.2. Drug discovery
8.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
8.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 9. Global Drug Discovery Informatics Market Overview, By Geography, 2015 - 2027 (USD Billion)
9.1. Global Drug Discovery Informatics Market Share, By Geography, 2015 - 2027 (USD Billion)
9.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
9.1.2. Market Share and CAGR Comparison, by Countries, 2020 & 2027 (%)
Chapter 10. North America Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1. North America Drug Discovery Informatics Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.2. North America Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
10.1.3. North America Drug Discovery Informatics Market Overview, By Functions, 2015 - 2027 (USD Billion)
10.1.4. North America Drug Discovery Informatics Market Overview, By End-users, 2015 - 2027 (USD Billion)
10.1.5. North America Drug Discovery Informatics Market Overview, By Application, 2015 - 2027 (USD Billion)
10.1.6. North America Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.6.1. U.S. Drug Discovery Informatics Market Overview, 2015 - 2027 (USD Billion)
10.1.6.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.1.2. U.S. Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
10.1.6.1.3. Other Segments
10.1.6.2. Canada Drug Discovery Informatics Market Overview, 2015 - 2027 (USD Billion)
10.1.6.2.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.2.2. Canada Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
10.1.6.2.3. Other Segments
10.1.6.3. Mexico Drug Discovery Informatics Market Overview, 2015 - 2027 (USD Billion)
10.1.6.3.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.3.2. Mexico Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
10.1.6.3.3. Other Segments
Chapter 11. Europe Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Europe Drug Discovery Informatics Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.2. Europe Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
11.1.3. Europe Drug Discovery Informatics Market Overview, By Functions, 2015 - 2027 (USD Billion)
11.1.4. Europe Drug Discovery Informatics Market Overview, By End-users, 2015 - 2027 (USD Billion)
11.1.5. Europe Drug Discovery Informatics Market Overview, By Application, 2015 - 2027 (USD Billion)
11.1.6. Europe Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.6.1. Germany
11.1.6.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.1.2. Germany Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
11.1.6.1.3. Others Segments
11.1.6.2. France
11.1.6.2.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.2.2. France Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
11.1.6.2.3. Others Segments
11.1.6.3. UK
11.1.6.3.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.3.2. UK Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
11.1.6.3.3. Others Segments
11.1.6.4. Italy
11.1.6.4.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.4.2. Italy Drug Discovery Informatics Market Overview, By Solutions 2015 - 2027 (USD Billion)
11.1.6.4.3. Others Segments
11.1.6.5. Spain
11.1.6.5.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.5.2. Spain Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
11.1.6.5.3. Others Segments
11.1.6.6. Rest of Europe
11.1.6.6.1. Market size and projections, 2015 – 2025
11.1.6.6.2. Rest of Europe Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
11.1.6.6.3. Others Segments
Chapter 12. Asia Pacific Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. Asia Pacific Drug Discovery Informatics Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.2. Asia Pacific Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
12.1.3. Asia Pacific Drug Discovery Informatics Market Overview, By Functions, 2015 - 2027 (USD Billion)
12.1.4. Asia Pacific Drug Discovery Informatics Market Overview, By End-users, 2015 - 2027 (USD Billion)
12.1.5. Asia Pacific Drug Discovery Informatics Market Overview, By Application, 2015 - 2027 (USD Billion)
12.1.6. Asia Pacific Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1.6.1. India
12.1.6.1.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.6.1.2. India Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
12.1.6.1.3. Other Segments
12.1.6.2. China
12.1.6.2.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.6.2.2. China Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
12.1.6.2.3. Other Segments
12.1.6.3. Japan
12.1.6.3.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.6.3.2. Japan Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
12.1.6.3.3. Other Segments
12.1.6.4. South Korea
12.1.6.4.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.6.4.2. South Korea Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
12.1.6.4.3. Other Segments
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.6.5.2. Rest of Asia Pacific Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
12.1.6.5.3. Other Segments
Chapter 13. Middle East & Africa Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1. Middle East & Africa Drug Discovery Informatics Market Overview, 2015 - 2027 (USD Billion)
13.1.1. Market size and projections, 2015 - 2027 (USD Billion)
13.1.2. Middle East & Africa Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
13.1.3. Middle East & Africa Drug Discovery Informatics Market Overview, By Functions, 2015 - 2027 (USD Billion)
13.1.4. Middle East & Africa Drug Discovery Informatics Market Overview, By End-users, 2015 - 2027 (USD Billion)
13.1.5. Middle East & Africa Drug Discovery Informatics Market Overview, By Application, 2015 - 2027 (USD Billion)
13.1.6. Middle East & Africa Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1.6.1. GCC
13.1.6.1.1. Market size and projections, 2015 - 2027 (USD Billion)
13.1.6.1.2. GCC Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
13.1.6.1.3. Other Segments
13.1.6.2. South Africa
13.1.6.2.1. Market size and projections, 2015 - 2027 (USD Billion)
13.1.6.2.2. South Africa Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
13.1.6.2.3. Other Segments
13.1.6.3. Rest of Middle East & Africa
13.1.6.3.1. Market size and projections, 2015 - 2027 (USD Billion)
13.1.6.3.2. Rest of Middle East & Africa Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
13.1.6.3.3. Other Segments
Chapter 14. South America Drug Discovery Informatics Market Overview, By Countries, 2015 - 2027 (USD Billion)
14.1. South America Drug Discovery Informatics Market Overview, 2015 - 2027 (USD Billion)
14.1.1. Market size and projections, 2015 - 2027 (USD Billion)
14.1.2. South America Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
14.1.3. South America Drug Discovery Informatics Market Overview, By Functions, 2015 - 2027 (USD Billion)
14.1.4. South America Drug Discovery Informatics Market Overview, By End-users, 2015 - 2027 (USD Billion)
14.1.5. South America Drug Discovery Informatics Market Overview, By Application, 2015 - 2027 (USD Billion)
14.1.6. South America Drug Discovery Informatics Market Overview, By Countries, 2015- 2026 (USD Billion)
14.1.7. Brazil
14.1.7.1. Market size and projections, 2015 - 2027 (USD Billion)
14.1.7.2. Brazil Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
14.1.7.3. Other Segments
14.1.8. Argentina
14.1.8.1. Market size and projections, 2015 - 2027 (USD Billion)
14.1.8.2. Argentina Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
14.1.8.3. Other Segments
14.1.9. Rest of South America
14.1.9.1. Market size and projections, 2015 – 2027
14.1.9.2. Rest of South America Drug Discovery Informatics Market Overview, By Solutions, 2015 - 2027 (USD Billion)
14.1.9.3. Other Segments
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2020
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New Distribution channel development
Chapter 16. Key Vendor Analysis
16.1. Charles River Laboratories International, Inc
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Distribution channel Benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. Thermo Fisher Scientific
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Distribution channel Benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. PerkinElmer Inc.
16.4. Biogen Inc
16.5. BoehringerIngelheim GmbH
16.6. Insilico Medicine, Inc
16.7. International Business Machines Corporation
16.8. Schrödinger
16.9. Albany Molecular Research Inc.
16.10. Certara
Chapter 17. Drug Discovery Informatics Market Cost Analysis
17.1. Drug Discovery Informatics Market Key Raw Material Analysis
17.1.1. Key Raw Material
17.1.2. Price Trend of Key Raw Material
17.1.3. Key Suppliers of Raw Material
17.1.4. Market Concentration Rate of Raw Material
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. Drug Discovery Informatics Market Industrial Chain Analysis
18.2. Upstream Raw Material Sourcing
18.3. Raw Material Source of Drug Discovery Informatics Market Major Manufacturers in 2021
18.4. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Compound weighing and dissolution
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Technology Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Technology Progress in Related Distribution channel
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Engine Powered of Suppliers
5. Engine Powered of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Drug Discovery Informatics Market share, By Solutions, 2020 & 2027 (%)
10. Global Drug Discovery Informatics Market share, by Software, By Solutions, 2020 & 2027 (USD Billion)
11. Global Drug Discovery Informatics Market share, by Services (AML), By Solutions, 2020 & 2027 (USD Billion)
12. Global Drug Discovery Informatics Market share, By Functions, 2020 & 2027 (%)
13. Global Drug Discovery Informatics Market share, by SEQUENCING, By Functions, 2020 & 2027 (USD Billion)
14. Global Drug Discovery Informatics Market share, by TARGET DATA ANALYSIS, By Functions, 2020 & 2027 (USD Billion)
15. Global Drug Discovery Informatics Market share, By End-users, 2020 & 2027 (%)
16. Global Drug Discovery Informatics Market share, by Contract research organizations, By End-users, 2020 & 2027 (USD Billion)
17. Global Drug Discovery Informatics Market share, by Pharmaceutical & biotechnology companies, By End-users, 2020 & 2027 (USD Billion)
18. Global Drug Discovery Informatics Market share, by Others, By End-users, 2020 & 2027 (USD Billion)
19. Global Drug Discovery Informatics Market share, By Application, 2020 & 2027 (%)
20. Global Drug Discovery Informatics Market share, by Drug development, By Application, 2020 & 2027 (USD Billion)
21. Global Drug Discovery Informatics Market share, by Drug discovery, By Application, 2020 & 2027 (USD Billion)
22. Global Drug Discovery Informatics Market share, by Region, 2020 & 2027 (%)
23. Global Drug Discovery Informatics Market share, by region, 2020 - 2027(USD Billion)
24. North America Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
25. North America Drug Discovery Informatics Market share, by Countries, 2020 & 2027 (%)
26. U.S. Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
27. Canada Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
28. Europe Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
29. Europe Drug Discovery Informatics Market share, by Countries, 2020 & 2027 (%)
30. Spain Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
31. UK Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
32. Italy Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
33. Germany Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
34. France Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
35. Rest of Europe Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
36. Asia-Pacific Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
37. Asia-Pacific Drug Discovery Informatics Market share, by Countries, 2020 & 2027 (%)
38. China Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
39. India Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
40. Australia Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
41. Japan Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
42. Rest of Asia-Pacific Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
43. Middle East & Africa Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
44. Middle East & Africa Drug Discovery Informatics Market share, by Countries, 2020 & 2027 (%)
45. GCC Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
46. South Africa Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
47. Rest Of Middle East & Africa Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
48. South America Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
49. Brazil Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
50. Mexico Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
51. Argentina Drug Discovery Informatics Market, 2020 - 2027(USD Billion)
52. Rest Of South America Drug Discovery Informatics Market, 2020 - 2027(USD Billion)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Drug Discovery Informatics Market, 2020-2027 (USD Billion)
4. Drug Discovery Informatics requirement, by country, 2020-2027, (USD Billion)
5. North America Drug Discovery Informatics Market, By Solutions, 2020-2027 (USD Billion)
6. North America Drug Discovery Informatics Market, By Functions, 2020-2027 (USD Billion)
7. North America Drug Discovery Informatics Market, By End user, 2020-2027 (USD Billion)
8. North America Drug Discovery Informatics Market, By Application, 2020-2027 (USD Billion)
9. Europe Drug Discovery Informatics Market, By Solutions, 2020-2027 (USD Billion)
10. Europe Drug Discovery Informatics Market, By Functions, 2020-2027 (USD Billion)
11. Europe Drug Discovery Informatics Market, By End user, 2020-2027 (USD Billion)
12. Europe Drug Discovery Informatics Market, By Application, 2020-2027 (USD Billion)
13. Asia Pacific Drug Discovery Informatics Market, By Solutions, 2020-2027 (USD Billion)
14. Asia Pacific Drug Discovery Informatics Market, By Functions, 2020-2027 (USD Billion)
15. Asia Pacific Drug Discovery Informatics Market, By End user, 2020-2027 (USD Billion)
16. Asia Pacific Drug Discovery Informatics Market, By Application, 2020-2027 (USD Billion)
17. Middle East & Africa Drug Discovery Informatics Market, By Solutions, 2020-2027 (USD Billion)
18. Middle East & Africa Drug Discovery Informatics Market, By Functions, 2020-2027 (USD Billion)
19. Middle East & Africa Drug Discovery Informatics Market, By End user, 2020-2027 (USD Billion)
20. Middle East & Africa Drug Discovery Informatics Market, By Application, 2020-2027 (USD Billion)
21. South America Drug Discovery Informatics Market, By Solutions, 2020-2027 (USD Billion)
22. South America Drug Discovery Informatics Market, By Functions, 2020-2027 (USD Billion)
23. South America Drug Discovery Informatics Market, By End user, 2020-2027 (USD Billion)
24. South America Drug Discovery Informatics Market, By Application, 2020-2027 (USD Billion)
25. Global Drug Discovery Informatics Market, Company Market Share, 2020 & 2027(%)
26. Charles River Laboratories International, Inc., : Product Benchmarking
27. Charles River Laboratories International, Inc., : Financial Performance
28. Thermo Fisher Scientific: Product Benchmarking
29. Thermo Fisher Scientific: Financial Performance
30. PerkinElmer Inc., : Product Benchmarking
31. PerkinElmer Inc., : Financial Performance
32. Biogen Inc. : Product Benchmarking
33. Biogen Inc. : Financial Performance
34. BoehringerIngelheim GmbH : Product Benchmarking
35. BoehringerIngelheim GmbH : Financial Performance
36. Insilico Medicine, Inc., : Product Benchmarking
37. Insilico Medicine, Inc., : Financial Performance
38. International Business Machines Corporation : Product Benchmarking
39. International Business Machines Corporation : Financial Performance
40. Schrödinger: Product Benchmarking
41. Schrödinger: Financial Performance
42. Albany Molecular Research Inc. : Product Benchmarking
43. Albany Molecular Research Inc. : Financial Performance
44. Certana: Product Benchmarking
45. Certana: Financial Performance

The Leading Key Players in Drug Discovery Informatics Market

Charles River Laboratories International Inc.
Thermo Fisher Scientific
PerkinElmer Inc.
Biogen Inc.
BoehringerIngelheim GmbH
Insilico Medicine Inc.
International Business Machines Corporation
Schrodinger LLC
Albany Molecular Research Inc. (AMRI)
Certara
L.P.